Loading clinical trials...
Loading clinical trials...
Early Statin-Ezetimibe Combination vs. Statin Monotherapy to Achieve LDL-C < 70 mg/dL in Recent Ischemic Stroke Patients With Evidence of Atherosclerosis: A Randomized Controlled Trial
Conditions
Interventions
statin + ezetimibe
Statin monotherapy (rosuvastatin or atorvastatin)
Locations
1
Taiwan
Chang Gung Memorial Hospital, Chiayi Branch
Pozi, Taiwan
Start Date
August 1, 2025
Primary Completion Date
July 31, 2029
Completion Date
July 31, 2029
Last Updated
December 30, 2025
NCT07392450
NCT07367100
NCT07318714
NCT05976685
NCT07107022
NCT07371455
Lead Sponsor
Chang Gung Memorial Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions